Alp Şen Foundation Ignite Registry Typing by NGS in Turkey

27/10/2016

Omixon today announce that Holotype HLA, the world’s leading NGS-based product for HLA genotyping has been selected and implemented by the Alp Şen Foundation in Turkey as the HLA genotyping solution of choice. Supply of Holotype HLA will officially be provided through GenPlus, Omixon’s distributor in Turkey – financial details...

Fishing for Reads – HLA Typing From Non-targeted Data

26/10/2016

What is non-targeted data? For the sake of this post, ‘non-targeted data’ will be used as a collective term for data with more than a dozen or so targeted genes. Whole exome or whole genome sequencing, whole MHC, or multi-gene panels all fall into this category. These data types...

Omixon “Rode the Bull” Again – ASHI, 2016

07/10/2016

Following on from the trends set last year, eight excited members of the Omixon Team went on a trip to outride the best in the rodeo of ASHI 2016 in St. Louis, MO. Thanks to One Lambda for including a mechanical bull to literally let the bull-times ride! Although...

NGS Accreditation with ASHI Standards at the ASHI Annual Meeting 2016

23/09/2016

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in four oral presentations and five poster presentations produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in St Louis, MO. Additionally, Omixon’s Lunch Symposium on Thursday...

Meet Our New Field Application Scientist in Europe, Dr. Libor Kolesár

08/09/2016

We are happy to announce that Dr. Libor Kolesár has recently joined our European FAS Team. Libor is the former co-director of the HLA Laboratory at the Department of Immunogenetics in IKEM, Prague, Czech Republic, where he spent 12 years of his career. During that period he achieved his PhD...